Piper Sandler analyst Adam Maeder maintained a Hold rating on Resmed (RMD – Research Report) today and set a price target of $260.00. The company’s shares closed yesterday at $257.65.
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Resmed (RMD – Research Report) today and set a price target of $250.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback